From the ∗Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital, University of Würzburg

†Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

‡Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

§The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD.

Received for publication November 22, 2023; revision accepted December 7, 2023.

M.F. and R.A.W. equally contributed to the study.

Conflicts of interest and sources of funding: This study was partially supported by the Okayama University “RECTOR” Program, KAKENHI grant (22H03027) from the Japan Society for the Promotion of Science (T.H.), and the German Research Foundation (453989101, R.A.W., T.H.; 507803309, R.A.W.). This work was supported by the Deutsche Forschungsgemeinschaft (DFG AL 203/1-1 and CRC/Transregio 205 “The Adrenal: Central Relay in Health and Disease”). R.A.W. and A.K.B. have received speaker honoraria from Novartis/AAA and PentixaPharm. R.A.W. reports advisory board work for Novartis/AAA and Bayer. A.K.B. is a member of the advisory board of PentixaPharm. All other authors declare no conflict of interest.

Correspondence to: Rudolf A. Werner, MD, Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany. E-mail: [email protected].